MAIN MENU
QUICK LINKS
CONNECT WITH US

Button
Coronavirus (COVID-19) updates, visitor restrictions and resources →
Now offering telemedicine through our Virtual Visit online program for primary care and specialty care visits → Virtual Visit appointments are available for new and existing UF Health patients. Check the FAQ section and Request an Appointment section below for more information.

Call (904) 383-1052 to make an appointment or call your physician’s office if you have questions specific to your health needs.

Clinical Trial Details

Title
Protocol: CFTY720DUS40 - Novartis Pharmaceuticals trial entitled: A 12-Month, prospective, multicenter, two-cohort, nonrandomized, open-label study in adult patients with Relapsing Multiple Sclerosis (RMS), to investigate changes in immune phenotype biomarkers after treatment with 0.5mg fingolimod (FTY720) [FLUENT]
Study Description

The purpose of the study is to collect extra blood samples in addition to your normal routine standard of care to study certain proteins in your blood called Biomarkers.

After the screening visit, you will begin the study period during which you will visit the study clinic four times i.e., Baseline, Month 3, Month 6 and Month 12. Besides your routine standard of care as indicated above, and after checking to see if you still qualify for the study, the following will take place for the purpose of this clinical study for patients in both Treatment Arms:

Open Enrollment
Contact Name: Yasmeen Shabbir
Contact Phone: (904) 244-9814
Contact Email: Yasmeen.shabbir@jax.ufl.edu
Investigators

Principal Investigator
Scott L. Silliman, M.D.
Neurology